Mounjaro®
Starting from £179.99/mo
Start journey Learn moreStomach pain on Wegovy (semaglutide) is common, especially in the first weeks of treatment or after a dose increase. Most people find it manageable with a few adjustable habits around food, timing and hydration. This is a prescription-only medicine, so any changes to your dose or schedule should always go through your prescriber. Here is what the evidence and clinical guidance actually suggest.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Semaglutide slows gastric emptying, which is part of how it reduces appetite. The downside is that food you would once have digested comfortably can sit heavily in the stomach, especially if portions are large or fat content is high. The practical fix is straightforward: eat less at one sitting, more often if needed, and cut back temporarily on fried or very rich food.
A quick check worth doing in under a minute: before you sit down to eat, glance at what is on the plate and ask whether it is roughly half the size of what you would have eaten six months ago. If it is not, halve it. Wegovy is already suppressing hunger, the plate size is often a habit rather than a need.
Eating slowly, chewing thoroughly and stopping the moment fullness arrives rather than when the plate is empty makes a meaningful difference. The causes of stomach pain on Wegovy are well documented, and portion size is consistently among the most modifiable factors.
Carbonated drinks, alcohol and very spicy food are worth avoiding during the first few weeks, none are banned, but all can worsen nausea and bloating when gastric emptying is already slowed. If you have noticed your symptoms flaring in a way that feels more like an illness than a side effect, our page on Wegovy and stomach flu explains how to tell the difference and what to do. Stick to plain water or diluted squash between meals.
Wegovy is injected once a week, and the timing of your injection relative to meals is not fixed by the prescriber, but small adjustments can help. Many people find that injecting on a day when they can eat lightly (a weekend morning, for example) means any peak nausea coincides with a relaxed schedule rather than a work lunch or a social meal.
The injection site rotation matters more than many people realise. Consistently injecting into the same spot can cause localised irritation that contributes to discomfort. Rotating between the abdomen, thigh and upper arm, as described in the Patient Information Leaflet, keeps tissue reaction to a minimum. For more background on injection placement, see our page on injecting Wegovy in the stomach area.
There is no clinical evidence that taking Wegovy at a specific time of day reduces GI side effects, but consistency matters: the same day each week keeps plasma levels stable. Erratic timing can cause peaks and troughs that may worsen symptoms.
Most stomach pain on Wegovy is an inconvenience, not a danger. But there are patterns that need prompt medical attention, not self-management.
The MHRA issued a Drug Safety Update in January 2026 highlighting acute pancreatitis as a known, infrequent but potentially serious side effect of GLP-1 medicines including semaglutide. The distinguishing feature is severe, persistent pain in the upper abdomen that does not ease, often spreading towards the back, sometimes accompanied by vomiting. This is not typical nausea from a dose increase. Call 111 or go to A&E rather than waiting to see whether it settles.
Gallbladder problems, including gallstones, have also been reported with GLP-1 medicines. Cramping pain in the upper right abdomen, particularly after eating fat, is worth reporting to your GP or prescriber rather than attributing it to routine side effects. You can report any suspected side effect directly through the MHRA Yellow Card scheme.
For a broader picture of what stomach-related symptoms on Wegovy typically look like and how they progress, the NHS medicines page on semaglutide gives a clear patient-level summary worth reading alongside your Patient Information Leaflet. More detail on the range of stomach pains that can occur on Wegovy is on our dedicated page.
Persisting through serious side effects without telling anyone is neither necessary nor a good idea. If stomach pain, nausea or vomiting is disrupting sleep, meals or work more than a week or two into a dose, your prescriber can slow the titration schedule. Spending an extra four weeks at a lower dose before stepping up is a legitimate, recognised clinical strategy, not a failure.
Anti-nausea medication is sometimes prescribed alongside GLP-1 treatments for people who struggle with the early weeks, though that is a clinical decision rather than something to self-prescribe. Do not adjust your dose independently.
If you are already on Wegovy and finding the side-effect picture hard to manage, our guide to stopping or pausing Wegovy covers what happens when treatment is interrupted and what to discuss with your prescriber before making that call. Understanding how Wegovy works as a treatment can also help set realistic expectations around the adjustment period.
People choosing a private route to treatment sometimes worry that raising concerns will result in their prescription being stopped. At nume (sorry, at the service) a real prescriber, not a chatbot, reads every follow-up. Clinical support exists to use. If you are considering starting Wegovy and want to understand what the supervised process looks like from the beginning, our weight-loss treatment page sets it out clearly.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.